Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy

被引:108
作者
Sharma, K
Lee, S
Han, S
Lee, S
Francos, B
McCue, P
Wassell, R
Shaw, MA
RamachandraRao, SP
机构
[1] Thomas Jefferson Univ, Ctr Diabet Kidney Dis, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dorrance Hamilton Res Labs, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Kimmel Canc Ctr, Proteom Core Facil, Philadelphia, PA 19107 USA
关键词
alpha; 1; antitrypsin; biomarkers; clinical study; elastin; kidney disease;
D O I
10.1002/pmic.200401288
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Urinary proteins may provide dues regarding pathogenesis of kidney disease as well as providing markers of disease activity. We employed two-dimensional differential in-gel electrophoretic analysis (2-D DIGE) to assess multiple urine samples in patients with diabetic nephropathy. Patient samples were collected as timed overnight collections. All the patients had longstanding diabetes, impaired renal function, and overt proteinuria. Control and patient urinary protein were analyzed by 2-D DIGE and DeCyder analysis. Ninety-nine spots were significantly regulated in the urine proteome of the diabetic samples, with 63 up- and 36 down-regulated. One spot corresponding to a pI 5-6 and a molecular weight between 45 and 66 kDa was consistently upregulated by 19-fold across individuals in the diabetic group. Surface-enhanced laser desorption/ionization-time of flight analysis of in-gel tryptic digest of this spot identified this protein as alpha 1 antitrypsin (AAT). ELISA of urine samples from a separate group of patients and controls confirmed a marked increase of AAT in diabetic patients. Immunostaining of human diabetic kidneys revealed up-regulation of AAT in areas of renal fibrosis. In conclusion, we developed a method to analyze numerous urine samples from patients and allowed for detection and identification of regulated urine protein spots.
引用
收藏
页码:2648 / 2655
页数:8
相关论文
共 16 条
[1]   URINARY-EXCRETION AND RENAL CLEARANCE OF SPECIFIC PLASMA-PROTEINS IN DIABETES OF SHORT AND LONG DURATION [J].
ARONOFF, SL ;
SCHNIDER, S ;
SMELTZER, J ;
MACKAY, W ;
TCHOU, P ;
RUSHFORTH, N ;
MILLER, M ;
BENNETT, PH .
DIABETES, 1981, 30 (08) :656-663
[2]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[3]   Specific activity of α1 proteinase inhibitor and α2macroglobulin in human serum:: Application to insulin-dependent diabetes mellitus [J].
Bristow, CL ;
Di Meo, F ;
Arnold, RR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 89 (03) :247-259
[4]   The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells [J].
Cutillas, PR ;
Chalkley, RJ ;
Hansen, KC ;
Cramer, R ;
Norden, AGW ;
Waterfield, MD ;
Burlingame, AL ;
Unwin, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (03) :F353-F364
[5]  
Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703
[6]  
GIOVANNI GF, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.38237.585000.7C
[7]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[8]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462
[9]   ELEVATION OF FACTOR-XLA ALPHA-1-ANTITRYPSIN COMPLEX LEVELS IN NIDDM PATIENTS WITH DIABETIC NEPHROPATHY [J].
MURAKAMI, T ;
KOMIYAMA, Y ;
EGAWA, H ;
MURATA, K .
DIABETES, 1993, 42 (02) :233-238
[10]   Proteomic-based detection of urine proteins associated with acute renal allograft rejection [J].
Schaub, S ;
Rush, D ;
Wilkins, J ;
Gibson, IW ;
Weiler, T ;
Sangster, K ;
Nicolle, L ;
Karpinski, M ;
Jeffry, J ;
Nickerson, P .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01) :219-227